Positive Trial Results of Mesoblast Cell Therapy in Post-Traumatic Osteoarthritis Published In Arthritis Research
Pettinga: Stock Market,
NEW YORK and MELBOURNE, Australia, Aug. 16, 2017 (GLOBE NEWSWIRE) -- (Nasdaq:MESO) (ASX:MSB) today announced that the Phase 2a…